JP2008521795A5 - - Google Patents

Download PDF

Info

Publication number
JP2008521795A5
JP2008521795A5 JP2007542513A JP2007542513A JP2008521795A5 JP 2008521795 A5 JP2008521795 A5 JP 2008521795A5 JP 2007542513 A JP2007542513 A JP 2007542513A JP 2007542513 A JP2007542513 A JP 2007542513A JP 2008521795 A5 JP2008521795 A5 JP 2008521795A5
Authority
JP
Japan
Prior art keywords
leptin
antagonist
seq
leptin antagonist
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007542513A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008521795A (ja
JP5113526B2 (ja
Filing date
Publication date
Priority claimed from US10/996,607 external-priority patent/US7307142B2/en
Application filed filed Critical
Publication of JP2008521795A publication Critical patent/JP2008521795A/ja
Publication of JP2008521795A5 publication Critical patent/JP2008521795A5/ja
Application granted granted Critical
Publication of JP5113526B2 publication Critical patent/JP5113526B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007542513A 2004-11-26 2005-11-24 レプチン拮抗薬 Expired - Fee Related JP5113526B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/996,607 2004-11-26
US10/996,607 US7307142B2 (en) 2004-11-26 2004-11-26 Leptin antagonists
PCT/IL2005/001250 WO2006056987A2 (en) 2004-11-26 2005-11-24 Leptin antagonists

Publications (3)

Publication Number Publication Date
JP2008521795A JP2008521795A (ja) 2008-06-26
JP2008521795A5 true JP2008521795A5 (https=) 2009-02-05
JP5113526B2 JP5113526B2 (ja) 2013-01-09

Family

ID=36204374

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007542513A Expired - Fee Related JP5113526B2 (ja) 2004-11-26 2005-11-24 レプチン拮抗薬

Country Status (8)

Country Link
US (1) US7307142B2 (https=)
EP (1) EP1814986B1 (https=)
JP (1) JP5113526B2 (https=)
CN (1) CN101189335B (https=)
AT (1) ATE498683T1 (https=)
DE (1) DE602005026432D1 (https=)
ES (1) ES2363011T3 (https=)
WO (1) WO2006056987A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8716220B2 (en) * 2005-09-07 2014-05-06 Nikolaos Tezapsidis Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid beta
US8227408B2 (en) * 2005-09-07 2012-07-24 Neurotez, Inc. Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
US8642543B2 (en) * 2005-09-07 2014-02-04 Neurotez, Inc. Methods for treating progressive cognitive disorders related to neurofibrillary tangles
US8778890B2 (en) 2009-03-31 2014-07-15 Temple University—Of the Commonwealth System of Higher Education Leptin antagonist and methods of use
AU2011243965A1 (en) 2010-04-22 2012-12-06 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center High affinity leptins and leptin antagonists
WO2014024189A1 (en) * 2012-08-06 2014-02-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Pegylated high affinity leptins with increased biological activity
IT1423968B1 (https=) * 2014-04-28 2016-08-26
US11123461B2 (en) 2015-02-26 2021-09-21 Remodeless Cv Ltd Treatment of ischemia and reperfusion using leptin antagonist
US10926006B2 (en) 2015-02-26 2021-02-23 Remodeless Cv Ltd Drug eluting stent
EP3261582B1 (en) 2015-02-26 2021-01-06 Remodeless CV Ltd. Methods and compositions relating to leptin antagonists
CN104829707B (zh) * 2015-05-06 2017-12-19 广东省生物资源应用研究所 一条cd环和e螺旋区突变的瘦素活性肽及其编码基因和应用
CN104829708B (zh) * 2015-05-06 2017-11-28 广东省生物资源应用研究所 一条d螺旋区突变的瘦素活性肽及其编码基因和应用
WO2017013270A1 (en) 2015-07-23 2017-01-26 Universite De Strasbourg Use of leptin signaling inhibitor for protecting kidneys from patients having ciliopathy
US10550192B2 (en) * 2016-11-08 2020-02-04 Regeneron Pharmaceuticals, Inc. Antigen-binding proteins that antagonize leptin receptor
DK3773713T3 (da) 2018-04-06 2025-08-18 Regeneron Pharma Leptinreceptoragonistantistof til anvendelse i forøgelse af knoglemasse hos et individ, der lider af metabolisk dysfunktion eller hypoleptinæmI
KR20210104744A (ko) 2018-12-18 2021-08-25 리제너론 파마슈티칼스 인코포레이티드 렙틴 수용체, gdf8 및 액티빈 a에 대한 길항제를 사용하여 체중 및 제지방 근육량을 향상시키기 위한 조성물 및 방법
WO2024050285A2 (en) * 2022-08-31 2024-03-07 The Board Of Trustees Of The Leland Stanford Junior University Leptin analogs for treating obesity and weight management

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
WO1997020933A2 (en) * 1995-12-06 1997-06-12 Schering Corporation MUTATIONAL VARIANTS OF MAMMALIAN Ob GENE PROTEINS
US20020160935A1 (en) 2000-03-24 2002-10-31 Smithkline Beecham Plc Use of leptin antagonists for the treatment of diabetes
CZ90999A3 (cs) 1996-09-20 1999-06-16 Hoechst Aktiengesellschaft Farmaceutický přípravek obsahující antagonistu leptinu vhodný pro léčení inzulínové rezistence u diabetes mellitus II. typu
HUP0402071A2 (hu) 2001-02-06 2005-01-28 Merck Patent Gmbh. Csökkentett immunogenitású, módosított leptin

Similar Documents

Publication Publication Date Title
JP2008521795A5 (https=)
JP2006506942A5 (https=)
RU2016103067A (ru) Улучшенные аминокислотные последовательности, направленные против респираторно-синцитиального вируса человека (hrsv), и полипептиды, включающие такие последовательности, для профилактики и/или лечения инфекций дыхательных путей
JP2011511753A5 (https=)
JP2009524429A5 (https=)
NO20025153D0 (no) FremgangsmÕter og sammensetninger for Õ svekke formering av HIV-1
JP2013515057A5 (https=)
JP2006512300A5 (https=)
NZ606427A (en) Extended recombinant polypeptides and compositions comprising same
JP2011502964A5 (https=)
JP2010529860A5 (https=)
HRP20150664T1 (hr) Antikancerogeni fuzijski protein
JP2003533186A5 (https=)
JP2009533317A5 (https=)
JP2010513327A5 (https=)
WO2007018619A3 (en) Chimeric therapeutic agents
JP2006514820A5 (https=)
DE602004027362D1 (de) Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320
JP2012518669A5 (https=)
JP2006514822A5 (https=)
EP1982992A4 (en) HLA BINDING PEPTIDE, PRE-STEP, DNA DOMAGING AND RECOMBINANT VECTOR
JP2008510468A5 (https=)
JP2019038772A5 (https=)
DE60234103D1 (de) Kontrolle des wachstums und der reparatur von gastrointestinalgewebe durch gastrokine
JP2007536910A5 (https=)